| Serial Number | 97273764 |
| Word Mark | VIZLUCI |
| Filing Date | Friday, February 18, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, December 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 4, 2023 |
| Goods and Services | Diagnostic agents, preparations, and substances for medical purposes; Imaging and therapeutic agents for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; Preparations and substances for medical purposes for detecting, diagnosing, and treating cancer, oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders; None of the foregoing for detecting, diagnosing, or treating diseases originating in the eye, with the exception of melanoma; medical diagnostic reagents; reagents for medical use; imaging and detection agents for diagnosing and monitoring cancer, and oncological diseases and disorders, brain and central nervous system diseases and disorders, skin and epithelial diseases and disorders, benign growths, metastatic disease, vascular lesions, blood diseases and disorders, vasculature diseases and disorders |
| Goods and Services | Medical research; scientific research; product research and development; product development in the field of the detection, location, and treatment of diseases; design and development of therapies, diagnostic agents, imaging agents, and medical devices for detecting, locating, and treating cancer and other diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 28, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 23, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Blaze Bioscience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98109 |
| Party Name | Blaze Bioscience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seattle, WA 98109 |
| Event Date | Event Description |
| Wednesday, August 24, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, February 22, 2022 | NEW APPLICATION ENTERED |
| Wednesday, February 23, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, August 19, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, August 24, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 24, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, February 25, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 28, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, February 28, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 28, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, February 28, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, February 28, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 15, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, April 4, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 4, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 2, 2023 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Tuesday, August 1, 2023 | OPPOSITION INSTITUTED NO. 999999 |
| Saturday, December 16, 2023 | OPPOSITION DISMISSED NO. 999999 |
| Wednesday, July 10, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, July 10, 2024 | SOU EXTENSION 1 FILED |
| Saturday, December 16, 2023 | OPPOSITION TERMINATED NO. 999999 |
| Saturday, December 16, 2023 | TTAB RELEASE CASE TO TRADEMARKS |
| Tuesday, January 30, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, July 10, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 10, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, December 18, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 18, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, December 18, 2024 | SOU EXTENSION 2 FILED |
| Thursday, December 19, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |